Valent BioSciences Opens New State-of-the-Art Addition at Melnik and Shafer Biorational Research Center

LIBERTYVILLE, Ill.--(BUSINESS WIRE)-- Valent BioSciences celebrated the grand opening of the new Venburg Wing at the company’s Melnik and Shafer Biorational Research Center in Libertyville, Illinois, during a special ceremony today. The event included remarks by Valent BioSciences senior leaders, local government and economic development officials, a ribbon cutting, plaque dedication, and refreshments for attendees and company employees.

Driven by business growth that has accelerated the need for additional research and development facilities, the state-of-the-art Venburg Wing includes new laboratory and pilot plant areas, offices, and meeting rooms. The space is named after Dr. Greg Venburg, Senior Director, Global Research at Valent BioSciences, who has served in a variety of leadership positions for the past 33 years. He currently manages the company’s interdisciplinary scientific research programs and research staff.

“This new wing in the Melnik and Shafer Biorational Research Center honors Greg’s many accomplishments over his long and distinguished career,” said Salman Mir, President and CEO of Valent BioSciences. “He has served in various R&D leadership roles and overseen the research, development, and introduction of major biorational technologies and products. Greg was also central to the planning, design, and construction of this facility and provided essential vision and leadership in forming the research teams working to develop innovative solutions to new and emerging biorational needs and opportunities. His contributions have been essential in helping us strengthen our industry leadership position.”

“I want to extend my congratulations to Valent BioSciences as they embark on this exciting expansion,” said Lake County Board Chair Sandy Hart. “Lake County is at the heart of life science and advanced manufacturing innovation because we have the talent, infrastructure, and resources to support growing companies and the quality of life their employees are looking for.”

“I’m thrilled to celebrate the Valent BioSciences expansion and am grateful for the firm’s long presence and continued investment in our community,” said Donna Johnson, Mayor, Village of Libertyville. “This is an example of the many innovative firms that continue to be attracted to the Village of Libertyville given the skilled employment base, strategic location, and supportive business environment.”

Valent BioSciences is also undertaking a major expansion at its Osage, Iowa, manufacturing facility that will be completed in early 2025. The additions include new production-scale fermentation and recovery equipment, a new pilot plant facility, and expanded laboratory space. To support its sustainability initiatives, the company has restored 34 acres of native prairie land adjacent to the Osage facility that will sequester approximately 170 metric tons of carbon dioxide annually, helping mitigate the effects of greenhouse gases in the environment. The company also operates a 12-acre solar field on land adjacent to the prairie that provides a portion of the Osage facility’s total annual electricity usage.

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd. Valent BioSciences is a global leader in the research, development, manufacturing, and commercialization of biorational products and technologies used in agriculture, public health, and forest health. Through its expertise in bioscience, Valent BioSciences helps growers profitably sustain their land and legacies and protects the public from insect-borne disease. The company has more than 60 years of experience bringing biorational products to market in more than 95 countries worldwide. Valent BioSciences is also the parent company of Mycorrhizal Applications LLC, a leading supplier of arbuscular mycorrhizal fungi-based products. For additional information, visit the company’s website at www.valentbiosciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240529098126/en/